INDOCO REMEDIES LIMITED
Location
Maharashtra
Founded
1947-08-23
Website
Risk Signals
86 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Healthcare Compliance and Regulations (32)
New Product Release (23)
Business Launches (12)
Equity Analysis & Ratings (11)
Product Quality Compliance (10)
Corporate Announcements (8)
Earnings Reports & Warnings (8)
Financial Reporting (7)
Market Trends (7)
Strategic Partnerships (7)
Investor Relations Updates (5)
Biodiversity Conservation (5)
Corporate Insolvency (5)
Corporate Rebranding (4)
Market Entry (4)
Acquisition Announcements (4)
Product Recall (3)
Stock Market Events (3)
Corporate Social Responsibility Initiatives (2)
Real Estate Projects (2)
Debt Strategy and Obligations (2)
Financial Reporting Irregularities (2)
Sustainable Business Practices (1)
Activism & Advocacy (1)
Artificial Intelligence Developments (1)
Asset Divestment (1)
Business Growth Initiatives (1)
Commodity Price Fluctuations (1)
Consumer Feedback and Complaints (1)
Consumer Protection Measures (1)
Recent Articles about INDOCO REMEDIES LIMITED
Live alerts from global media, monitored by Business Radar
(cnbctv18.com)
Indoco Remedies gets USFDA nod for Cetirizine tablets, shares surge 3% - CNBC TV18
Indoco Remedies secures USFDA approval for Cetirizine Tablets, marking another milestone in its OTC portfolio. Shares surge over 3%, while the company plans its US launch of Lofexidine Tablets soon
Read more